Hohimer Wealth Management LLC Makes New $3.79 Million Investment in CVS Health Corporation $CVS

Key Points

• Hohimer Wealth Management initiated a CVS Health position, buying 44,290 shares valued at approximately $3.795 million in the third quarter.
• CVS beat quarterly expectations, reporting adjusted earnings of $2.09 per share and revenue of $108.4 billion; revenue rose 5.4% year over year, and the company raised its outlook.
• Analysts maintain a “Moderate Buy” consensus, with an average price target of $108.25; several firms recently cut their targets while retaining positive ratings.

Hohimer Wealth Management LLC bought a new stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 44,290 shares of the pharmacy operator's stock, valued at approximately $3,795,000.

Other hedge funds have also bought and sold shares of the company. Kilter Group LLC bought a new position in shares of CVS Health in the second quarter worth about $27,000. J.Safra Asset Management Corp purchased a new position in shares of CVS Health during the 2nd quarter valued at about $30,000. Beaird Harris Wealth Management LLC grew its stake in shares of CVS Health by 201.0% during the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator's stock valued at $30,000 after acquiring an additional 195 shares during the period. Timbuktu Capital Management LLC bought a new position in shares of CVS Health during the 2nd quarter valued at approximately $31,000. Finally, Dunhill Financial LLC purchased a new stake in CVS Health in the 2nd quarter worth approximately $32,000. Institutional investors own 80.66% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the stock. Sanford C. Bernstein restated an "outperform" rating and set a $112.00 target price on shares of CVS Health in a research note on Wednesday, September 9th. UBS Group dropped their price target on shares of CVS Health from $118.00 to $107.00 and set a "buy" rating for the company in a research report on Thursday. Leerink Partners reduced their price objective on shares of CVS Health from $112.00 to $104.00 and set an "outperform" rating for the company in a research note on Thursday. BMO Capital Markets set a $112.00 price objective on shares of CVS Health in a research report on Wednesday, September 9th. Finally, Barclays lowered their target price on shares of CVS Health from $108.00 to $107.00 and set an "overweight" rating on the stock in a research note on Thursday. Twenty-two equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $108.25.

Insider Activity at CVS Health

In related news, EVP Prem Shah bought 23,855 shares of the company's stock in a transaction that occurred on Friday, November 6th. The stock was purchased at an average price of $83.89 per share, for a total transaction of $2,001,195.95. Following the completion of the transaction, the executive vice president owned 88,516 shares in the company, valued at $7,425,607.24. The trade was a 36.89% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.85% of the company's stock.

CVS Health Stock Performance

NYSE:CVS opened at $83.76 on Monday. The stock has a 50-day moving average price of $90.37 and a 200 day moving average price of $88.89. The stock has a market capitalization of $107.17 billion, a P/E ratio of 9.75, a P/E/G ratio of 0.73 and a beta of 0.58. CVS Health Corporation has a 12-month low of $69.51 and a 12-month high of $110.68. The company has a current ratio of 0.85, a quick ratio of 0.66 and a debt-to-equity ratio of 0.71.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 EPS for the quarter, topping analysts' consensus estimates of $1.65 by $0.44. CVS Health had a return on equity of 13.65% and a net margin of 2.62%. The company had revenue of $108.40 billion for the quarter, compared to analysts' expectations of $104.72 billion. During the same period in the previous year, the firm earned $1.60 EPS. The firm's revenue was up 5.4% compared to the same quarter last year. Equities research analysts forecast that CVS Health Corporation will post 8.25 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd were given a dividend of $0.6650 per share. The ex-dividend date was Thursday, October 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.2%. CVS Health's dividend payout ratio (DPR) is presently 30.97%.

Key Headlines Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Executive Vice President Prem Shah bought 23,855 shares for about $2 million, increasing his direct stake by 36.9%. The sizable purchase may signal confidence in CVS’s prospects. SEC filing
• Positive Sentiment: CVS beat third-quarter earnings and revenue estimates and raised its 2026 outlook, with Aetna’s recovery among the factors supporting the improved outlook. Q3 earnings call coverage
• Neutral Sentiment: UBS lowered its price target to $107 but maintained a Buy rating, indicating continued optimism while reflecting a more cautious valuation. UBS rating
• Negative Sentiment: The planned separation of the retail pharmacy business from the insurance and pharmacy-benefit operations by 2028 has raised questions about execution, costs, and the value of the two businesses. The announcement overshadowed the earnings beat and was followed by a sharp selloff. Breakup and stock reaction
• Negative Sentiment: Additional concerns include weaker Medicare ratings and AM Best placing ratings for Aetna subsidiaries under review, creating uncertainty around the insurance business. Medicare ratings coverage

CVS Health Profile

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division.

The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.